-
1
-
-
38449089313
-
The problem of transplanting the sensitized patient whose problem is it?
-
Jackson AM, Zachary AA. The problem of transplanting the sensitized patient whose problem is it? Front Biosci 2008: 13: 1396-412.
-
(2008)
Front Biosci
, vol.13
, pp. 1396-1412
-
-
Jackson, A.M.1
Zachary, A.A.2
-
2
-
-
0023083856
-
Public epitopes and the antigenic structure of the HLA molecules.
-
Rodey GE, Fuller TC. Public epitopes and the antigenic structure of the HLA molecules. Crit Rev Immunol 1987: 7: 229-67.
-
(1987)
Crit Rev Immunol
, vol.7
, pp. 229-267
-
-
Rodey, G.E.1
Fuller, T.C.2
-
3
-
-
33750365602
-
Immunoregulation by targeting T cells in the treatment of allergy and asthma.
-
Larché M. Immunoregulation by targeting T cells in the treatment of allergy and asthma. Curr Opin Immunol 2006: 18: 745-50.
-
(2006)
Curr Opin Immunol
, vol.18
, pp. 745-750
-
-
Larché, M.1
-
4
-
-
70449901330
-
An immunological overview of allergen specific immunotherapy - subcutaneous and sublingual routes.
-
Ozdemir C. An immunological overview of allergen specific immunotherapy - subcutaneous and sublingual routes. Ther Adv Respir Dis 2009: 3: 253-63.
-
(2009)
Ther Adv Respir Dis
, vol.3
, pp. 253-263
-
-
Ozdemir, C.1
-
5
-
-
0142103746
-
Intravenous immune globulins: an update for clinicians.
-
Knezevic-Maramic I, Kruskall MS. Intravenous immune globulins: an update for clinicians. Transfusion 2003: 43: 1460-80.
-
(2003)
Transfusion
, vol.43
, pp. 1460-1480
-
-
Knezevic-Maramic, I.1
Kruskall, M.S.2
-
6
-
-
0025102027
-
Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.
-
Sullivan KM, Kopecky KJ, Jocom J et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Engl J Med 1990: 323: 705-12.
-
(1990)
N Engl J Med
, vol.323
, pp. 705-712
-
-
Sullivan, K.M.1
Kopecky, K.J.2
Jocom, J.3
-
7
-
-
0027228037
-
Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg).
-
Glotz D, Haymann J-P, Sansonetti N et al. Suppression of HLA-specific alloantibodies by high-dose intravenous immunoglobulins (IVIg). Transplantation 1993: 56: 335-7.
-
(1993)
Transplantation
, vol.56
, pp. 335-337
-
-
Glotz, D.1
Haymann, J.2
Sansonetti, N.3
-
8
-
-
0042838104
-
Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.
-
Jordan SC, Vo A, Bunnapradist S et al. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients. Transplantation 2003: 76: 631-6.
-
(2003)
Transplantation
, vol.76
, pp. 631-636
-
-
Jordan, S.C.1
Vo, A.2
Bunnapradist, S.3
-
9
-
-
9644262465
-
Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial.
-
Jordan SC, Tyan D, Stablein D et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial. J Am Soc Nephrol 2004: 15: 3256-62.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 3256-3262
-
-
Jordan, S.C.1
Tyan, D.2
Stablein, D.3
-
10
-
-
77951823581
-
Use of intravenous immune globulin and Rituximab for desensitization of highly HLA-Sensitized patients awaiting kidney transplantation.
-
Vo AA, Peng A, Toyoda M et al. Use of intravenous immune globulin and Rituximab for desensitization of highly HLA-Sensitized patients awaiting kidney transplantation. Transplantation 2010: 89: 1095-102.
-
(2010)
Transplantation
, vol.89
, pp. 1095-1102
-
-
Vo, A.A.1
Peng, A.2
Toyoda, M.3
-
11
-
-
67651027514
-
Intravenous immunoglobulin a natural regulator of immunity and inflammation.
-
Jordan SC, Toyoda M, Vo AA. Intravenous immunoglobulin a natural regulator of immunity and inflammation. Transplantation 2009: 88: 1-6.
-
(2009)
Transplantation
, vol.88
, pp. 1-6
-
-
Jordan, S.C.1
Toyoda, M.2
Vo, A.A.3
-
12
-
-
0345237270
-
Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients.
-
John R, Lietz K, Burke E et al. Intravenous immunoglobulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients. Circulation 1999: 100 II: 229-35.
-
(1999)
Circulation
, vol.100
, Issue.2
, pp. 229-235
-
-
John, R.1
Lietz, K.2
Burke, E.3
-
13
-
-
18144386902
-
Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens.
-
Appel JZ, Hartwig MG, Davis RD, Reinsmoen NL. Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens. Hum Immunol 2005: 66: 378-86.
-
(2005)
Hum Immunol
, vol.66
, pp. 378-386
-
-
Appel, J.Z.1
Hartwig, M.G.2
Davis, R.D.3
Reinsmoen, N.L.4
-
14
-
-
0032572976
-
Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action.
-
Jordan SC, Quartel AW, Czer LS et al. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998: 66: 800-5.
-
(1998)
Transplantation
, vol.66
, pp. 800-805
-
-
Jordan, S.C.1
Quartel, A.W.2
Czer, L.S.3
-
15
-
-
0035863090
-
A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection.
-
Casadei DH, Del C rial M, Opelz G et al. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 2001: 71: 53-8.
-
(2001)
Transplantation
, vol.71
, pp. 53-58
-
-
Casadei, D.H.1
Del C rial, M.2
Opelz, G.3
-
16
-
-
2442677763
-
Intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection.
-
Moger V, RaviShankar MS, Sakjuja V et al. Intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Transplantation 2004: 77: 1455-6.
-
(2004)
Transplantation
, vol.77
, pp. 1455-1456
-
-
Moger, V.1
RaviShankar, M.S.2
Sakjuja, V.3
-
17
-
-
33645002093
-
Clearance studies during subsequent sessions of double filtration plasmapheresis.
-
Yeh JH, Chen WH, Chiu HC, Bai CH. Clearance studies during subsequent sessions of double filtration plasmapheresis. Artif Organs 2006: 30: 111-4.
-
(2006)
Artif Organs
, vol.30
, pp. 111-114
-
-
Yeh, J.H.1
Chen, W.H.2
Chiu, H.C.3
Bai, C.H.4
-
18
-
-
78650014921
-
Introduction and overview of therapeutic apheresis.
-
Okafor C, Ward DM, Mokrzycki MH, Weinstein R, Clark P, Balogun RA. Introduction and overview of therapeutic apheresis. J Clin Apher 2010: 25: 240-49.
-
(2010)
J Clin Apher
, vol.25
, pp. 240-249
-
-
Okafor, C.1
Ward, D.M.2
Mokrzycki, M.H.3
Weinstein, R.4
Clark, P.5
Balogun, R.A.6
-
19
-
-
37549049397
-
Double-filtration plasmapheresis.
-
Tanabe K. Double-filtration plasmapheresis. Transplantation 2007: 84: S30-2.
-
(2007)
Transplantation
, vol.84
-
-
Tanabe, K.1
-
20
-
-
0031881657
-
Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A sepharose.
-
Braun N, Gutenberger S, Erley CM, Risler T. Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A sepharose. Transfus Sci 1998: 19 (Suppl): 25-31.
-
(1998)
Transfus Sci
, vol.19
, Issue.SUPPL
, pp. 25-31
-
-
Braun, N.1
Gutenberger, S.2
Erley, C.M.3
Risler, T.4
-
21
-
-
32544450007
-
Desensitization protocols improving access and outcome in transplantation.
-
Zachary AA, Montgomery RA, Leffell MS. Desensitization protocols improving access and outcome in transplantation. Clin Appl Immunol Rev 2005: 5: 373-95.
-
(2005)
Clin Appl Immunol Rev
, vol.5
, pp. 373-395
-
-
Zachary, A.A.1
Montgomery, R.A.2
Leffell, M.S.3
-
22
-
-
11144232667
-
Transplanting patients with a positive donor-specific crossmatch: a single center's perspective.
-
Montgomery RA, Zachary AA. Transplanting patients with a positive donor-specific crossmatch: a single center's perspective. Pediatr Transplantation 2004: 8: 535-42.
-
(2004)
Pediatr Transplantation
, vol.8
, pp. 535-542
-
-
Montgomery, R.A.1
Zachary, A.A.2
-
23
-
-
0035993661
-
Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match.
-
Sonnenday CJ, Ratner LE, Zachary AA et al. Preemptive therapy with plasmapheresis/intravenous immunoglobulin allows successful live donor renal transplantation in patients with a positive cross-match. Transplant Proc 2002: 34: 1614-6.
-
(2002)
Transplant Proc
, vol.34
, pp. 1614-1616
-
-
Sonnenday, C.J.1
Ratner, L.E.2
Zachary, A.A.3
-
24
-
-
0344152841
-
Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients.
-
Zachary AA, Montgomery RA, Ratner LE et al. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients. Transplantation 2003: 76: 1519-25.
-
(2003)
Transplantation
, vol.76
, pp. 1519-1525
-
-
Zachary, A.A.1
Montgomery, R.A.2
Ratner, L.E.3
-
25
-
-
0034721477
-
Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidney to be successfully transplanted into cross-match positive recipients.
-
Montgomery RA, Zachary AA, Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidney to be successfully transplanted into cross-match positive recipients. Transplantation 2000: 70: 887-95.
-
(2000)
Transplantation
, vol.70
, pp. 887-895
-
-
Montgomery, R.A.1
Zachary, A.A.2
Racusen, L.C.3
-
26
-
-
77953958281
-
Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange.
-
Warren DS, Montgomery RA. Incompatible kidney transplantation: lessons from a decade of desensitization and paired kidney exchange. Immunol Res 2010: 47: 257-64.
-
(2010)
Immunol Res
, vol.47
, pp. 257-264
-
-
Warren, D.S.1
Montgomery, R.A.2
-
27
-
-
0034722728
-
A high panel-reactive antibody rescue protocol for cross-match positive live donor kidney transplant.
-
Schweitzer EJ, Wilson JS, Fernandez-Vina M. A high panel-reactive antibody rescue protocol for cross-match positive live donor kidney transplant. Transplantation 2000: 70: 1531-36.
-
(2000)
Transplantation
, vol.70
, pp. 1531-1536
-
-
Schweitzer, E.J.1
Wilson, J.S.2
Fernandez-Vina, M.3
-
28
-
-
10744232533
-
Overcoming a positive crossmatch in living-donor kidney transplantation.
-
Gloor JM, DeGoey SR, Pineda AA et al. Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant 2003: 34: 1017-23.
-
(2003)
Am J Transplant
, vol.34
, pp. 1017-1023
-
-
Gloor, J.M.1
DeGoey, S.R.2
Pineda, A.A.3
-
29
-
-
59649116354
-
Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience.
-
Thielke JJ, West-Thielke PM, Herren HL et al. Living donor kidney transplantation across positive crossmatch: the University of Illinois at Chicago experience. Transplantation 2009: 87: 268-73.
-
(2009)
Transplantation
, vol.87
, pp. 268-273
-
-
Thielke, J.J.1
West-Thielke, P.M.2
Herren, H.L.3
-
30
-
-
76649096333
-
Desensitization and renal transplant: plasmapheresis/IVIG standard dose in patients with high immunologic risk.
-
Flores-Gama F, Mondragón-Ramirez GA, Bochicchio- Riccardelli T. Desensitization and renal transplant: plasmapheresis/IVIG standard dose in patients with high immunologic risk. Cir Cir 2009: 77: 369-74.
-
(2009)
Cir Cir
, vol.77
, pp. 369-374
-
-
Flores-Gama, F.1
Mondragón-Ramirez, G.A.2
Bochicchio- Riccardelli, T.3
-
31
-
-
0033038283
-
Plasmapheresis, intravenous cytomegalovirus-specific immunoglobulin and reversal of antibody-mediated rejection in a pediatric renal transplant recipient: a case report.
-
Furth S, Neu AM, Hart J, Zachary A, Colomban P, Fivush BA. Plasmapheresis, intravenous cytomegalovirus-specific immunoglobulin and reversal of antibody-mediated rejection in a pediatric renal transplant recipient: a case report. Pediatr Transplant 1999: 3: 149-49.
-
(1999)
Pediatr Transplant
, vol.3
, pp. 149-249
-
-
Furth, S.1
Neu, A.M.2
Hart, J.3
Zachary, A.4
Colomban, P.5
Fivush, B.A.6
-
32
-
-
10744228964
-
Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection.
-
Rocha PN, Butterly DW, Greenberg A et al. Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. Transplantation 2003: 75: 1490-5.
-
(2003)
Transplantation
, vol.75
, pp. 1490-1495
-
-
Rocha, P.N.1
Butterly, D.W.2
Greenberg, A.3
-
33
-
-
4544296842
-
Successful rescue therapy with plasmapoheresis and intravenous immunoglobulin for acute humoral renal transplant rejection.
-
White NB, Greenstein SM, Cantafio AW et al. Successful rescue therapy with plasmapoheresis and intravenous immunoglobulin for acute humoral renal transplant rejection. Transplantation 2004: 78: 772-74.
-
(2004)
Transplantation
, vol.78
, pp. 772-774
-
-
White, N.B.1
Greenstein, S.M.2
Cantafio, A.W.3
-
34
-
-
18144382600
-
Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation.
-
Lehrich RW, Rocha PN, Reinsmoen N et al. Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. Hum Immunol 2005: 66: 350-58.
-
(2005)
Hum Immunol
, vol.66
, pp. 350-358
-
-
Lehrich, R.W.1
Rocha, P.N.2
Reinsmoen, N.3
-
35
-
-
29544447059
-
Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
-
Ibernon M, Gil-Vernet S, Carrera M et al. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation. Transplant Proc 2005: 37: 3743-5.
-
(2005)
Transplant Proc
, vol.37
, pp. 3743-3745
-
-
Ibernon, M.1
Gil-Vernet, S.2
Carrera, M.3
-
36
-
-
0032775558
-
Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation.
-
Pisani BA, Mullen Gm, Malinowska K et al. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant 1999: 18: 701-6.
-
(1999)
J Heart Lung Transplant
, vol.18
, pp. 701-706
-
-
Pisani, B.A.1
Mullen, G.2
Malinowska, K.3
-
37
-
-
33745629586
-
Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin.
-
Leech SH, Lopez-Cepero M, LeFor WM et al. Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin. Clin Transplant 2006: 20: 476-84.
-
(2006)
Clin Transplant
, vol.20
, pp. 476-484
-
-
Leech, S.H.1
Lopez-Cepero, M.2
LeFor, W.M.3
-
38
-
-
34748914694
-
Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population.
-
Pollock-BarZiv SM, Den Hollander N, Ngan BY et al. Pediatric heart transplantation in human leukocyte antigen sensitized patients: evolving management and assessment of intermediate-term outcomes in a high-risk population. Circulation 2007: 116 (Suppl 1): 172-8.
-
(2007)
Circulation
, vol.116
, Issue.SUPPL 1
, pp. 172-178
-
-
Pollock-BarZiv, S.M.1
Den Hollander, N.2
Ngan, B.Y.3
-
39
-
-
0023576832
-
Present experiences in a series of 26 ABO-incompatible living donor renal allografts.
-
Alexandre GP, Squifflet JP, DeBruyere M et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987: 19: 4538-48.
-
(1987)
Transplant Proc
, vol.19
, pp. 4538-4548
-
-
Alexandre, G.P.1
Squifflet, J.P.2
DeBruyere, M.3
-
40
-
-
33947580557
-
Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation - single center analysis.
-
Ishida H, Mayamoto N, Shirakawa H et al. Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation - single center analysis. Am J Transplant 2007: 7: 825-31.
-
(2007)
Am J Transplant
, vol.7
, pp. 825-831
-
-
Ishida, H.1
Mayamoto, N.2
Shirakawa, H.3
-
41
-
-
59849096365
-
Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
-
Tanabe K, Ishida H, Shimizu T, Omoto K, Shirakawa H, Tokumoto T. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens. Contrib Nephrol 2009: 162: 61-74.
-
(2009)
Contrib Nephrol
, vol.162
, pp. 61-74
-
-
Tanabe, K.1
Ishida, H.2
Shimizu, T.3
Omoto, K.4
Shirakawa, H.5
Tokumoto, T.6
-
43
-
-
3042746307
-
Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy.
-
Sonnenday CJ, Warren DS, Cooper M et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy. Am J Transplant 2004: 4: 1315-22.
-
(2004)
Am J Transplant
, vol.4
, pp. 1315-1322
-
-
Sonnenday, C.J.1
Warren, D.S.2
Cooper, M.3
-
44
-
-
32544442087
-
ABO incompatible high titer renal transplantation without splenectomy or anti-CD20 treatment.
-
Segev DL, Simpkins CE, Warren DS et al. ABO incompatible high titer renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005: 5: 2570-5.
-
(2005)
Am J Transplant
, vol.5
, pp. 2570-2575
-
-
Segev, D.L.1
Simpkins, C.E.2
Warren, D.S.3
-
45
-
-
65549126350
-
ABO incompatible renal transplantation: a paradigm ready for broad implementation.
-
Montgomery RA, Locke JE, King KE et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 2009: 87: 1246-55.
-
(2009)
Transplantation
, vol.87
, pp. 1246-1255
-
-
Montgomery, R.A.1
Locke, J.E.2
King, K.E.3
-
46
-
-
77951210109
-
ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation.
-
Tobian AAR, Shirey RS, Montgomery RA et al. ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation. Am J Transplant 2010: 10: 1247-53.
-
(2010)
Am J Transplant
, vol.10
, pp. 1247-1253
-
-
Tobian, A.A.R.1
Shirey, R.S.2
Montgomery, R.A.3
-
47
-
-
3943110993
-
Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
-
Gloor MM, DeGoey S, Ploeger N et al. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation. Transplantation 2004: 78: 221-7.
-
(2004)
Transplantation
, vol.78
, pp. 221-227
-
-
Gloor, M.M.1
DeGoey, S.2
Ploeger, N.3
-
48
-
-
34247241237
-
14th International HLA and immunogenetics workshop: report on understanding antibodies in transplantation.
-
Zachary AA, Montgomery RA, Jordan SC, Reinsmoen NL, Claas FJH, Reed EF. 14th International HLA and immunogenetics workshop: report on understanding antibodies in transplantation. Tissue Antigens 2007: 69 (Suppl 1): 160-73.
-
(2007)
Tissue Antigens
, vol.69
, Issue.SUPPL 1
, pp. 160-173
-
-
Zachary, A.A.1
Montgomery, R.A.2
Jordan, S.C.3
Reinsmoen, N.L.4
Claas, F.J.H.5
Reed, E.F.6
-
49
-
-
77952041825
-
Barriers to successful transplantation of the sensitized patient.
-
Zachary AA, Leffell MS. Barriers to successful transplantation of the sensitized patient. Expert Rev Clinc Immunol 2010: 6: 449-60.
-
(2010)
Expert Rev Clinc Immunol
, vol.6
, pp. 449-460
-
-
Zachary, A.A.1
Leffell, M.S.2
-
50
-
-
33745865957
-
Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration.
-
Jindra PR, Zhang X, Mulder A et al. Anti-HLA antibodies can induce endothelial cell survival or proliferation depending on their concentration. Transplantation 2006: 82: S33-5.
-
(2006)
Transplantation
, vol.82
-
-
Jindra, P.R.1
Zhang, X.2
Mulder, A.3
-
51
-
-
4444319472
-
Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway.
-
Narayanan K, Jaramillo A, Phelan DL, Mohanakumar T. Pre-exposure to sub-saturating concentrations of HLA class I antibodies confers resistance to endothelial cells against antibody complement-mediated lysis by regulating Bad through the phosphatidylinositol 3-kinase/Akt pathway. Eur J Immunol 2004: 34: 2303-12.
-
(2004)
Eur J Immunol
, vol.34
, pp. 2303-2312
-
-
Narayanan, K.1
Jaramillo, A.2
Phelan, D.L.3
Mohanakumar, T.4
-
52
-
-
70350132232
-
Effect of antibodies on endothelium.
-
Zhang X, Reed EF. Effect of antibodies on endothelium. Am J Transplant 2009: 9: 2459-65.
-
(2009)
Am J Transplant
, vol.9
, pp. 2459-2465
-
-
Zhang, X.1
Reed, E.F.2
-
53
-
-
68049147592
-
Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody.
-
Locke JE, Zachary AA, Warren DS. Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. Am J Transplant 2009: 9: 2136-9.
-
(2009)
Am J Transplant
, vol.9
, pp. 2136-2139
-
-
Locke, J.E.1
Zachary, A.A.2
Warren, D.S.3
-
54
-
-
67649619522
-
Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients.
-
Kopchaliiska D, Zachary AA, Montgomery RA, Leffell MS. Reconstitution of peripheral allospecific CD19+ B-cell subsets after B-lymphocyte depletion therapy in renal transplant patients. Transplantation 2009: 87: 1394-401.
-
(2009)
Transplantation
, vol.87
, pp. 1394-1401
-
-
Kopchaliiska, D.1
Zachary, A.A.2
Montgomery, R.A.3
Leffell, M.S.4
-
55
-
-
18144419717
-
Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin.
-
Zachary AA, Montgomery RA, Leffell MS. Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin. Hum Immunol 2005: 66: 364-70.
-
(2005)
Hum Immunol
, vol.66
, pp. 364-370
-
-
Zachary, A.A.1
Montgomery, R.A.2
Leffell, M.S.3
-
56
-
-
76949097232
-
Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols.
-
Montgomery RA. Renal transplantation across HLA and ABO antibody barriers: integrating paired donation into desensitization protocols. Am J Transplant 2010: 10: 449-57.
-
(2010)
Am J Transplant
, vol.10
, pp. 449-457
-
-
Montgomery, R.A.1
|